The success of Eso-SPONGE® therapy in the treatment of anastomotic dehiscence after Ivor-Lewis subtotal esophagectomy: A case report.
Eso-SPONGE®
Esophageal anastomosis
Esophageal dehiscence case report
Esophagectomy
Ivor-Lewis's technique
Surgery of esophagus
Journal
International journal of surgery case reports
ISSN: 2210-2612
Titre abrégé: Int J Surg Case Rep
Pays: Netherlands
ID NLM: 101529872
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
27
09
2021
revised:
14
10
2021
accepted:
14
10
2021
pubmed:
24
10
2021
medline:
24
10
2021
entrez:
23
10
2021
Statut:
ppublish
Résumé
Eso-SPONGE® has proved to be an excellent method for the treatment of persistent dehiscence of the intrathoracic esophagogastric anastomosis during the operation of subtotal esophagectomy sec. Ivor Lewis. The case presented is of a 72-year-old patient with esophageal adenocarcinoma (ADK) who underwent sub-total esophagectomy and esophagoplasty sec. Ivor Lewis complicated by an esophageal leak. The Eso-SPONGE® therapy has been successful halving the index of inflammation after the first two sessions and generation of a neowall after seven sessions. Eso-SPONGE® therapy has proven to be a valuable resource as a treatment for esophageal anastomotic dehiscences because it is easily repeatable in suburban centers, provided that they have a digestive endoscopy specialized in the positioning process. Eso-SPONGE® is a minimally invasive method that delivers excellent results in the treatment of fragile patients, such as those who have post-esophageal anastomotic dehiscence.
Identifiants
pubmed: 34688073
pii: S2210-2612(21)01027-0
doi: 10.1016/j.ijscr.2021.106525
pmc: PMC8536516
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
106525Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.